Rights and permissions
About this article
Cite this article
No additional benefit of using shorter-acting NMBs and opioids. Pharmacoecon. Outcomes News 172, 7 (1998). https://doi.org/10.1007/BF03277678
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03277678